Allarity Therapeutics, Inc.

Allarity Therapeutics, Inc.verified

ALLR

Price:

$1.16

Market Cap:

$16.85M

Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microtubule inhibitor for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 cli...[Read more]

Industry

Biotechnology

IPO Date

2021-12-21

Stock Exchange

NASDAQ

Ticker

ALLR

The ROE as of December 2025 (TTM) for Allarity Therapeutics, Inc. (ALLR) is -112.05%

According to Allarity Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -112.05%. This represents a change of 272.98% compared to the average of -30.04% of the last 4 quarters.

Allarity Therapeutics, Inc. (ALLR) Historical ROE (quarterly & annually)

How has ALLR ROE performed in the past?

The mean historical ROE of Allarity Therapeutics, Inc. over the last ten years is -221.16%. The current -112.05% ROE has changed -49.34% with respect to the historical average. Over the past ten years (40 quarters), ALLR's ROE was at its highest in in the March 2023 quarter at 926.55%. The ROE was at its lowest in in the December 2017 quarter at -158.36%.

Quarterly (TTM)
Annual

Average

-221.16%

Median

-75.22%

Minimum

-1242.95%

Maximum

432.61%

Allarity Therapeutics, Inc. (ALLR) ROE by Quarter and Year

Discovering the peaks and valleys of Allarity Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.66%

Maximum Annual ROE = 432.61%

Minimum Annual Increase = -150.92%

Minimum Annual ROE = -1242.95%

Quarterly (TTM)
Annual
YearROEChange
2024-207.56%-147.98%
2023432.61%-150.92%
2022-849.63%498.90%
2021-141.87%650.88%
2020-18.89%-76.27%
2019-79.62%726.85%
2018-9.63%-99.23%
2017-1242.95%1.66%
2016-70.82%204.53%
2015-23.26%-73.29%

Allarity Therapeutics, Inc. (ALLR) Average ROE

How has ALLR ROE performed in the past?

The current ROE of Allarity Therapeutics, Inc. (ALLR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-208.19%

5-year avg

-157.07%

10-year avg

-221.16%

Allarity Therapeutics, Inc. (ALLR) ROE vs. Peers

How is ALLR’s ROE compared to its peers?

Allarity Therapeutics, Inc.’s ROE is greater than Cingulate Inc. (-842.45%), greater than Processa Pharmaceuticals, Inc. (-342.35%), greater than BriaCell Therapeutics Corp. (-439.74%), greater than Lexaria Bioscience Corp. (-149.35%), greater than Entero Therapeutics, Inc. (-31.69%), greater than Lixte Biotechnology Holdings, Inc. (-308.56%), less than Clearside Biomedical, Inc. (65.87%), greater than Kairos Pharma, Ltd. (-79.19%), less than Curis, Inc. (354.21%), less than CASI Pharmaceuticals, Inc. (358.32%),

Build a custom stock screener for Allarity Therapeutics, Inc. (ALLR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Allarity Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Allarity Therapeutics, Inc. (ALLR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Allarity Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Allarity Therapeutics, Inc.'s ROE?

How is the ROE calculated for Allarity Therapeutics, Inc. (ALLR)?

What is the highest ROE for Allarity Therapeutics, Inc. (ALLR)?

What is the 3-year average ROE for Allarity Therapeutics, Inc. (ALLR)?

What is the 5-year average ROE for Allarity Therapeutics, Inc. (ALLR)?

How does the current ROE for Allarity Therapeutics, Inc. (ALLR) compare to its historical average?